Metalloprotein inhibitors
View Patent ↗The present invention relates to metalloprotein inhibitors comprising: a. an organic substituent and at least one zinc binding group (ZBG) covalently attached thereto; or b. a ZBG substituted by a side chain wherein the ZBG is of formula (I): wherein X is O or S and each R 1 , R 2 , R 3 , and R 4 is individually hydrogen or an organic radical. The metalloprotein inhibitors are useful for preventing or treating a pathological disease, condition, or symptom that is associated with pathological metalloprotein activity and/or that is alleviated by inhibition of said activity.
1. A compound of formula:
wherein X is O or S, and R 1 is a substituent of formula [(C 6 -C 10 )aryl] x -[(C 6 -C 10 )aryl] q -[O] p —[(C 6 -C 10 )aryl]-[O] r —[(C 1 -C 6 )alkyl] o -[N(R)]—[C(O)]— wherein each of o, r, p, q and x is independently 0 or 1, and wherein R is H, (C 1 -C 4 )alkyl, phenyl, or benzyl;
or a pharmaceutically-acceptable salt thereof.
2. A compound of formula:
wherein X is O or S, and R 1 is a substituent of formula [(C 6 -C 10 )aryl] x -[(C 6 -C 10 )aryl] q -[O] p —[(C 6 -C 10 )aryl]-[O] r —[(C 1 -C 6 )alkyl] o -[N(R)]—[C(O)]— wherein each of o, r, p, q and x is independently 0 or 1, and wherein R is H, (C 1 -C 4 )alkyl, phenyl, or benzyl; wherein an aryl group of R 1 is further substituted with (C 1 -C 6 )alkyl, halo, (C 1 -C 6 )alkoxy, heteroaryl, styryl, phenyl, CN, sulfonamide, amino or NO 2 ; or a pharmaceutically acceptable salt thereof.
3. A compound of the formula:
or a pharmaceutically acceptable salt thereof.
4. A composition comprising a compound of claim 1 in combination with a pharmaceutically acceptable carrier or diluent.
5. A compound of the formula
or a pharmaceutically acceptable salt thereof.